Date:- 29 September, 2022
Location:- Paris

Jacques Fieschi, Vice President R&D Immuno-Oncology, Veracyte, will introduce Veracyte’s capabilities in multimodal analysis taking part in the round table “Multiparametric signatures for precision medicine” together with Pr Fabrice ANDRE, Director of Research, Institut Gustave Roussy, Cristina D’ALMEIDA, Scientific Director, MEDEXPRIM and Sophie LE RICOUSSE, Head of Biology Transfer and Innovation Department, INCa.

For more information: